Trial Profile
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Eye disorders
- Focus Therapeutic Use
- 28 May 2016 New trial record